235 related articles for article (PubMed ID: 12193195)
1. Intravenous cocaine induced-activity and behavioural sensitization in norepinephrine-, but not dopamine-transporter knockout mice.
Mead AN; Rocha BA; Donovan DM; Katz JL
Eur J Neurosci; 2002 Aug; 16(3):514-20. PubMed ID: 12193195
[TBL] [Abstract][Full Text] [Related]
2. Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines.
Morón JA; Brockington A; Wise RA; Rocha BA; Hope BT
J Neurosci; 2002 Jan; 22(2):389-95. PubMed ID: 11784783
[TBL] [Abstract][Full Text] [Related]
3. Cocaine, reward, movement and monoamine transporters.
Uhl GR; Hall FS; Sora I
Mol Psychiatry; 2002; 7(1):21-6. PubMed ID: 11803442
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference.
Sora I; Hall FS; Andrews AM; Itokawa M; Li XF; Wei HB; Wichems C; Lesch KP; Murphy DL; Uhl GR
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5300-5. PubMed ID: 11320258
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms underlying the rewarding effects of cocaine.
Hall FS; Sora I; Drgonova J; Li XF; Goeb M; Uhl GR
Ann N Y Acad Sci; 2004 Oct; 1025():47-56. PubMed ID: 15542699
[TBL] [Abstract][Full Text] [Related]
6. Cocaine-conditioned locomotion in dopamine transporter, norepinephrine transporter and 5-HT transporter knockout mice.
Hall FS; Li XF; Randall-Thompson J; Sora I; Murphy DL; Lesch KP; Caron M; Uhl GR
Neuroscience; 2009 Sep; 162(4):870-80. PubMed ID: 19482066
[TBL] [Abstract][Full Text] [Related]
7. Lack of cocaine effect on dopamine clearance in the core and shell of the nucleus accumbens of dopamine transporter knock-out mice.
Budygin EA; John CE; Mateo Y; Jones SR
J Neurosci; 2002 May; 22(10):RC222. PubMed ID: 12006604
[TBL] [Abstract][Full Text] [Related]
8. Studies of the biogenic amine transporters. 10. Characterization of a novel cocaine binding site in brain membranes prepared from dopamine transporter knockout mice.
Rothman RB; Carroll FI; Morales M; Rowley DL; Rice KC; Dersch CM; Donovan DM
Synapse; 2002 May; 44(2):94-105. PubMed ID: 11891881
[TBL] [Abstract][Full Text] [Related]
9. Hypolocomotor effects of acute and daily d-amphetamine in mice lacking the dopamine transporter.
Spielewoy C; Biala G; Roubert C; Hamon M; Betancur C; Giros B
Psychopharmacology (Berl); 2001 Dec; 159(1):2-9. PubMed ID: 11797063
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic expression of the targeted null-mutation in the dopamine transporter gene varies as a function of the genetic background.
Morice E; Denis C; Giros B; Nosten-Bertrand M
Eur J Neurosci; 2004 Jul; 20(1):120-6. PubMed ID: 15245485
[TBL] [Abstract][Full Text] [Related]
11. Evidence of long-term expression of behavioral sensitization to both cocaine and ethanol in dopamine transporter knockout mice.
Morice E; Denis C; Giros B; Nosten-Bertrand M
Psychopharmacology (Berl); 2010 Jan; 208(1):57-66. PubMed ID: 19937000
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the behavioral effects of the repeated administration of PTT, 2beta-propanoyl-3beta-(4-tolyl)tropane and cocaine.
Freedland CS; Smith HR; Hart SL; Daunais JB; Davies HM; Porrino LJ
Brain Res; 2000 Jun; 869(1-2):98-104. PubMed ID: 10865063
[TBL] [Abstract][Full Text] [Related]
13. Cocaine mechanisms: enhanced cocaine, fluoxetine and nisoxetine place preferences following monoamine transporter deletions.
Hall FS; Li XF; Sora I; Xu F; Caron M; Lesch KP; Murphy DL; Uhl GR
Neuroscience; 2002; 115(1):153-61. PubMed ID: 12401330
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationship studies of 4-[2-(diphenylmethoxy)ethyl]-1-benzylpiperidine derivatives and their N-analogues: evaluation of O-and N-analogues and their binding to monoamine transporters.
Dutta AK; Fei XS; Beardsley PM; Newman JL; Reith ME
J Med Chem; 2001 Mar; 44(6):937-48. PubMed ID: 11300876
[TBL] [Abstract][Full Text] [Related]
15. Serotonin, dopamine and norepinephrine transporter mRNAs: heterogeneity of distribution and response to 'binge' cocaine administration.
Burchett SA; Bannon MJ
Brain Res Mol Brain Res; 1997 Oct; 49(1-2):95-102. PubMed ID: 9387868
[TBL] [Abstract][Full Text] [Related]
16. Preprodynorphin mediates locomotion and D2 dopamine and mu-opioid receptor changes induced by chronic 'binge' cocaine administration.
Bailey A; Yoo JH; Racz I; Zimmer A; Kitchen I
J Neurochem; 2007 Sep; 102(6):1817-1830. PubMed ID: 17532787
[TBL] [Abstract][Full Text] [Related]
17. Voltammetric assessment of dopamine clearance in the absence of the dopamine transporter: no contribution of other transporters in core or shell of nucleus accumbens.
Mateo Y; Budygin EA; John CE; Banks ML; Jones SR
J Neurosci Methods; 2004 Dec; 140(1-2):183-7. PubMed ID: 15589348
[TBL] [Abstract][Full Text] [Related]
18. Stimulant and reinforcing effects of cocaine in monoamine transporter knockout mice.
Rocha BA
Eur J Pharmacol; 2003 Oct; 479(1-3):107-15. PubMed ID: 14612142
[TBL] [Abstract][Full Text] [Related]
19. Dopamine transporter-dependent and -independent actions of trace amine beta-phenylethylamine.
Sotnikova TD; Budygin EA; Jones SR; Dykstra LA; Caron MG; Gainetdinov RR
J Neurochem; 2004 Oct; 91(2):362-73. PubMed ID: 15447669
[TBL] [Abstract][Full Text] [Related]
20. Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters.
Shen HW; Hagino Y; Kobayashi H; Shinohara-Tanaka K; Ikeda K; Yamamoto H; Yamamoto T; Lesch KP; Murphy DL; Hall FS; Uhl GR; Sora I
Neuropsychopharmacology; 2004 Oct; 29(10):1790-9. PubMed ID: 15226739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
